Clinuvel Pharmaceuticals Limited (ASX: CUV)
Australia
· Delayed Price · Currency is AUD 12.10
-0.10 (-0.82%)
Jan 31, 2025, 4:10 PM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 604.36 million as of January 31, 2025. Its market cap has decreased by -22.72% in one year.
Market Cap
604.36M
Enterprise Value
421.37M
Revenue
88.18M
Ranking
n/a
PE Ratio
17.34
Stock Price
12.10
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 604.36M, an increase of 11,465.15%. That is a compound annual growth rate of 21.91%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 135.79B |
| Pro Medicus | 29.09B |
| Cochlear | 20.91B |
| Sonic Healthcare | 13.71B |
| Telix Pharmaceuticals | 9.82B |
| Ramsay Health Care | 7.73B |
| Ansell | 5.12B |
| Sigma Healthcare | 4.51B |